Palladium Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $11.7M | Sell |
48,240
-1,812
| -4% | -$416K | 0.51% | 58 |
|
|
2021
Q4 | $11.3M | Sell |
50,052
-870
| -2% | -$184K | 0.46% | 59 |
|
|
2021
Q3 | $10.8M | Sell |
50,922
-1,256
| -2% | -$289K | 0.49% | 57 |
|
|
2021
Q2 | $12.7M | Sell |
52,178
-811
| -2% | -$200K | 0.6% | 48 |
|
|
2021
Q1 | $13.2M | Sell |
52,989
-2,244
| -4% | -$535K | 0.65% | 47 |
|
|
2020
Q4 | $12.7M | Sell |
55,233
-4,646
| -8% | -$1.07M | 0.7% | 43 |
|
|
2020
Q3 | $15.2M | Sell |
59,879
-1,686
| -3% | -$418K | 0.96% | 29 |
|
|
2020
Q2 | $14.5M | Sell |
61,565
-234
| -0.4% | -$53.4K | 0.99% | 25 |
|
|
2020
Q1 | $12.5M | Sell |
61,799
-1,600
| -3% | -$349K | 1.04% | 24 |
|
|
2019
Q4 | $15.3M | Sell |
63,399
-16,282
| -20% | -$3.59M | 0.98% | 28 |
|
|
2019
Q3 | $16.5M | Buy |
79,681
+11,075
| +16% | +$2.13M | 1.15% | 23 |
|
|
2019
Q2 | $12.6M | Sell |
68,606
-3,341
| -5% | -$598K | 0.87% | 33 |
|
|
2019
Q1 | $13.7M | Sell |
71,947
-5,848
| -8% | -$1.12M | 0.98% | 32 |
|
|
2018
Q4 | $15.1M | Sell |
77,795
-2,195
| -3% | -$428K | 1.21% | 20 |
|
|
2018
Q3 | $16.6M | Sell |
79,990
-2,101
| -3% | -$414K | 1.13% | 22 |
|
|
2018
Q2 | $15.2M | Sell |
82,091
-28,265
| -26% | -$5M | 1.1% | 25 |
|
|
2018
Q1 | $18.8M | Sell |
110,356
-257
| -0.2% | -$47.2K | 1.39% | 18 |
|
|
2017
Q4 | $19.2M | Sell |
110,613
-1,930
| -2% | -$342K | 1.39% | 18 |
|
|
2017
Q3 | $21M | Buy |
112,543
+343
| +0.3% | +$60.8K | 1.6% | 15 |
|
|
2017
Q2 | $19.3M | Buy |
112,200
+158
| +0.1% | +$25.7K | 1.53% | 18 |
|
|
2017
Q1 | $18.4M | Buy |
112,042
+2,079
| +2% | +$345K | 1.48% | 19 |
|
|
2016
Q4 | $16.1M | Buy |
109,963
+3,307
| +3% | +$498K | 1.36% | 20 |
|
|
2016
Q3 | $17.8M | Buy |
106,656
+5,700
| +6% | +$964K | 1.55% | 16 |
|
|
2016
Q2 | $15.4M | Buy |
100,956
+2,739
| +3% | +$426K | 1.4% | 19 |
|
|
2016
Q1 | $14.7M | Sell |
98,217
-1,381
| -1% | -$205K | 1.35% | 20 |
|
|
2015
Q4 | $16.2M | Sell |
99,598
-125
| -0.1% | -$19.6K | 1.5% | 18 |
|
|
2015
Q3 | $13.8M | Buy |
99,723
+692
| +0.7% | +$109K | 1.36% | 21 |
|
|
2015
Q2 | $15.2M | Sell |
99,031
-2,596
| -3% | -$416K | 1.36% | 18 |
|
|
2015
Q1 | $16.2M | Sell |
101,627
-20,772
| -17% | -$3.27M | 1.39% | 19 |
|
|
2014
Q4 | $19.5M | Sell |
122,399
-466
| -0.4% | -$72.6K | 1.69% | 12 |
|
|
2014
Q3 | $17.3M | Sell |
122,865
-881
| -0.7% | -$115K | 1.55% | 14 |
|
|
2014
Q2 | $14.6M | Sell |
123,746
-1,152
| -0.9% | -$133K | 1.3% | 22 |
|
|
2014
Q1 | $15.4M | Buy |
124,898
+1,096
| +0.9% | +$133K | 1.41% | 17 |
|
|
2013
Q4 | $14.1M | Buy |
123,802
+298
| +0.2% | +$33.9K | 1.34% | 20 |
|
|
2013
Q3 | $13.8M | Sell |
123,504
-2,245
| -2% | -$243K | 1.4% | 16 |
|
|
2013
Q2 | $12.4M | Buy |
+125,749
| New | +$13M | 1.31% | 18 |
|
Other funds holding AMGN
Palladium Partners's AMGN Position: Q1 2022 in Review
Palladium Partners reduced its Amgen (AMGN) stake by 3.6% in Q1 2022, selling an estimated $416K and leaving 48,240 shares worth $11.7M. The position accounts for 0.51% of the portfolio, ranked #58.
Palladium Partners first reported a position in AMGN in Q2 2013 and has held it in 36 quarters since. The position peaked at $21M in Q3 2017. 2,338 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.
- Palladium Partners held 48,240 shares of Amgen worth $11.7M as of Q1 2022.
- Palladium Partners sold 1,812 Amgen shares in Q1 2022, an estimated $416K.
- Amgen made up 0.51% of Palladium Partners's portfolio in Q1 2022, its #58 holding.
- Palladium Partners first reported a position in Amgen in Q2 2013 and has held it in 36 quarters since.
- Palladium Partners's Amgen position peaked at $21M in Q3 2017.
- 2,338 funds tracked by Wall St. Rank held Amgen as of Q1 2022.
Based on Palladium Partners's 13F filing for Q1 2022, filed 26 Apr 2022.